本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
台灣新竹，2023年11月01日 — 筑波醫電(ACE Biotek)和台灣網路認證(TWCA) 近日宣布簽署合作備忘錄，本次合作主要機緣來自雙方對醫療資訊安全的關注。智慧醫院發展進程常面臨資訊安全及實現具有法律效力的文件簽署等重大挑戰，因此促使筑波醫電與TWCA攜手合作，在無需更動既有筑波Uniiform智慧電子病歷手寫系統前提下，融合TWCA電子簽章和數位憑證技術，提供紀錄簽署數位軌跡、數位化儲存文件功能。 筑波醫電致力於醫療領域的智慧化解決方案，成功推動許多科別智慧化，特別是透過Uniiform和DS智慧上傳閘道器實現手繪病歷的電子化和儀器資料的擷取與解析。TWCA是全球知名的網路認證服務提供商，擁有卓越的資訊安全專業，提供資訊安全解決方案，如數位簽章、憑證和身分識別等。筑波醫電董事長特助暨資安長陳嘉文表示：「這次合作為醫院提供更安全和便捷的手寫電子表單和簽署體驗，基於個人對資訊安全和醫療領域的深厚背景，很榮幸促使筑波醫電與TWCA開展了跨領域合作」。兩家公司的合作充分利用各自的優勢，可望簡化醫院資訊部門的工作流程，並提供具有法律效益的文件機制。 本次合作的兩大重點是Uniiform電子簽署方案和DS設備身分識別方案。Uniiform是筑波醫電的核心產品，可以實現即時數位化的紙本書寫和簽署，同時保留使用者的手寫習慣，並可提供收執。透過整合TWCA的資訊安全解決方案，Uniiform電子簽署解決方案具有實務上的法律效益，並提供可追溯的簽署記錄，可同時滿足線上數位化申請及線下簽署需求。DS設備身分識別方案旨在確保院內各設備都具有身分識別機制，使醫院能夠快速追溯設備的操作歷史，有助於提高醫院設備的資訊安全性。 在醫療資安議題日益受到關注的情況下，對法律效益的電子簽署的需求不斷增加。筑波醫電和TWCA的合作將開創醫療資訊安全領域的新趨勢，為醫院提供科學且可靠的解決方案，協助醫療產業導入數位化申辦與簽署機制，以確保病患資料和數據的安全性。未來有望擴大市場應用，滿足醫院和政府部門的需求，期望提升台灣醫療產業的資訊安全數位轉型，同時為全球醫療產業提供一個值得參考的標竿。 關於筑波醫電ACE Biotek 筑波醫電大樓是董事長許深福先生驅動內心的寄望及理念，依據建築設計師、施工團隊及同仁們很科學的作品。是筑波人多年來文化、創意技術的展現，是筑波全體同仁長久對生醫產業接軌國際平台的堅持。筑波科技集團以豐富的無線通訊軟硬體整合經驗、結合半導體晶片、醫學影像演算法、雲端技術、人工智慧、臨床醫師專業、法規驗證與專利技術綜效，著力於人們早期病變篩檢系統的精準醫療設備產品研發與生產。期望不但可以減少病患及家人的遺憾，並開拓台灣本土精密無創微創醫檢設備能量且推廣於國際，更建立台灣從3C到三醫(醫才、醫技、醫材)的產業鏈轉型平台與人才的培育之目標。 連絡筑波醫電 筑波醫電股份有限公司Advanced ACE Biotek Co., Ltd. 地址：30261新竹縣竹北市生醫二路66號 (新竹生醫園區) 電話: +886-3-5500909 E-mail: service@acebiotek.com 網站: https://www.acebiotek.com/ Facebook: https://www.facebook.com/Acebiotek/ LinkedIn: https://www.linkedin.com/company/30620922/admin/
Hsinchu, Taiwan - November 1, 2023 - ACE Biotek and TAIWAN-CA (TWCA) proudly announce the signing of a MOU to address the critical concerns of information security in the healthcare sector. The development of smart hospitals often needs to improve information security and the establishment of legally binding document signatures. To meet these challenges, ACE Biotek has collaborated with TWCA to seamlessly integrate TWCA's electronic signature and digital certificate technology into the existing ACE Biotek Uniiform digital handwriting system. This integration aims to provide a comprehensive solution that records digital signature trails and facilitates digital document storage. As a pioneer of intelligent solutions in the healthcare industry, ACE Biotek has successfully led numerous departments toward digital transformation. Through products like Uniiform and DS, ACE Biotek has digitized handwritten medical records and enabled the capture and analysis of instrument data. TWCA, a globally recognized network authentication service provider, excels in information security and offers solutions such as digital signatures, certificates, and identity verification. Mr. KC Chen, Chairman's Assistant, and Chief Information Security Officer of ACE Biotek, expressed his enthusiasm for this interdisciplinary collaboration, stating, "This partnership enhances the security and convenience of handwritten electronic forms and signatures in hospitals. Leveraging our strong backgrounds in information security and the medical field, ACE Biotek and TWCA have embarked on this cross-disciplinary endeavor." The collaboration between the two companies harnesses their respective strengths and aims to streamline the workflow of hospital IT departments. Moreover, it establishes mechanisms for legally binding documents. The primary focus of this cooperation is on Uniiform's electronic signature solution and DS device identity verification. Uniiform, a core product of ACE Biotek, enables real-time digitalization of handwritten documents while retaining users' handwriting habits and providing history records. By integrating TWCA's information security solutions, the Uniiform electronic signature solution ensures practical legal effectiveness and traceable signature records, satisfying both online digital application and offline signing needs. The DS device identity verification solution aims to guarantee the identity of all hospital devices, enabling quick traceability of device operation history to enhance information security within the healthcare facility. With the increasing focus on healthcare information security, the demand for legally effective electronic signatures continues to grow. The partnership between ACE Biotek and TWCA will pioneer new trends in healthcare information security. It will provide scientific and reliable solutions for hospitals to implement digital applications and signing mechanisms, ensuring the security of patient data and information. The future outlook includes expanding market applications to meet the needs of hospitals and government agencies. This collaboration is expected to drive Taiwan's healthcare industry toward secure digital transformation and serve as a reference point for the global medical sector. About ACE Biotek Established in 2000, ACE Group has grown over 20 years across wireless and healthcare industries. ACE Biotek, founded in 2018 by President Steve Hsu, integrates 20 years of industrial experience and knowledge to solve unmet clinical needs. ACE Biotek develops smart medical solutions encompassing imaging algorithms, cloud computing, artificial intelligence, and terahertz technology, with a focus on achieving early disease diagnosis. In the long term, ACE Biotek aims to expand globally, serving as a platform to foster talent and support tech companies in their transformation into Medtech. Contact ACE Biotek Advanced ACE Biotek Co., Ltd. Address: Hsinchu Biomedical Science Park, No. 66, Shengyi 2nd Rd., Zhubei City, Hsinchu County 302, Taiwan Phone: +886-3-5500909 E-mail: service@acebiotek.com Website: https://www.acebiotek.com/ Facebook: https://www.facebook.com/Acebiotek/ LinkedIn: https://www.linkedin.com/company/30620922/admin/
ACE Biotek, known for its successful implementation of smart hospital solutions, officially signed a cooperation memorandum with TWCA on May 30, 2023. The collaboration aims to enhance the partnership between Uniipen smart pen technology and electronic signature applications, working together to create mutual value. Stephen Lee, Chairman of TWCA, and Steve Hsu, President of ACE Biotek, represented the signing ceremony. TWCA is a leading global provider of network certification services dedicated to driving digital transformation and providing secure and reliable authentication solutions. Its innovative technology and excellent service quality have earned complete customer trust. As the pioneer from 3C to the medical industry, ACE Biotek combines its expertise in wireless communication hardware and software integration with AI platform technology to develop smart medical data upload solutions. These solutions are applied to electronic medical record digitization and instrument data acquisition and analysis, with successful collaborations and implementations in representative domestic hospitals. The signing of this MOU aims to combine the technical strengths of both parties by integrating electronic signature or encryption technology into smart handwriting applications. Steve Hsu, President of ACE Biotek, stated that the signing of this cooperation memorandum represents an innovative strategy. In addition to being used for EMR, Uniiform smart handwriting system is also utilized with the Data Stream Gateway (DS), which retrieves and integrates device data. By combining it with TWCA's electronic signature technology in the future, the applications can be expanded from healthcare to other industries. Integration with companies in the science park makes it possible to introduce the technology into more underserved areas. Stephen Lee, Chairman of TWCA, also emphasized that this collaboration will focus on the innovative integration of electronic signatures with Uniipen smart pens. It represents the perfect combination of both companies' core competencies and business focus. Through cooperation with ACE Biotek, the goal is to provide customers with a superior, convenient, and secure experience in handwritten electronic forms. The success of this collaboration is expected to bring continued growth and mutual value to both parties.
筑波醫電在智慧醫院方案導入具成果，於2023年05月30日與臺灣網路認證股份有限公司TWCA正式簽署合作備忘錄，提升Uniipen智慧筆技術與電子簽章應用之合作，攜手創造共贏價值，簽約代表由臺灣網路認證董事長李榮琳、筑波醫電董事長許深福代表簽署。 臺灣網路認證是全球領先的網路認證服務提供商，致力推動數位化轉型，為客戶提供安全可靠的認證解決方案，其創新性的技術和卓越的服務品質贏得了廣泛的客戶信賴。筑波集團為3C到三醫的領航者，結合無線通訊軟硬體整合經驗、AI平台技術開發智慧醫療上傳方案，應用於手寫病歷電子化及儀器資料擷取解析，與國內代表性醫院皆有合作與導入實績，本次MOU簽署為結合雙方技術優勢，將電子簽章或加密技術加成於智慧手寫應用。 筑波醫電董事長許深福表示，此次合作備忘錄之簽署為創新的策略，Uniiform智慧手寫筆除了用於EMR之外，筑波亦使用智慧上傳閘道器(Data Stream Gateway, DS)解析儀器資料，將表單與IoT數據及資安系統整合，未來與TWCA電子簽章技術結合，可以將應用從醫療拓展至其他產業，透過與科學園區廠商接軌，能導入更多未滿足之場域。 TWCA董事長李榮琳也強調，這次合作將聚焦於將電子簽章結合Uniipen智慧筆帶來創新，為兩家公司核心競爭力和業務主軸的完美結合，透過與筑波醫電的合作，將能夠為客戶帶來更優質、便捷且安全的手寫電子表單體驗，期許這次合作的成功為雙方帶來持續增長和共贏的價值。 關於筑波醫電 筑波醫電大樓是董事長許深福先生驅動內心的寄望及理念，依據建築設計師、施工團隊及同仁們很科學的作品。是筑波人多年來文化、創意技術的展現，是筑波全體同仁長久對生醫產業接軌國際平台的堅持。筑波科技集團以豐富的無線通訊軟硬體整合經驗、結合半導體晶片、醫學影像演算法、雲端技術、人工智慧、臨床醫師專業、法規驗證與專利技術綜效，著力於人們早期病變篩檢系統的精準醫療設備產品研發與生產。期望不但可以減少病患及家人的遺憾，並開拓台灣本土精密無創微創醫檢設備能量且推廣於國際，更建立台灣從3C到三醫(醫才、醫技、醫材)的產業鏈轉型平台與人才的培育之目標。 連絡我們 筑波醫電股份有限公司Advanced ACE Biotek Co., Ltd. 地址：30261新竹縣竹北市生醫二路66號 (新竹生醫園區) 電話: +886-3-5500909 E-mail: service@acebiotek.com 網站: https://www.acebiotek.com/ Facebook: https://www.facebook.com/Acebiotek/ LinkedIn: https://www.linkedin.com/company/30620922/admin/
A12 藝術空間
台灣網路認證
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
